Dozens of alumni of a group the State Department has linked to espionage have secured jobs in sensitive industries.

Neil Gallagher M.D., Ph.D., former AbbVie Chief Medical Officer and President of R&D at Syndax, brings considerable experience in oncology drug ...

The Washington, D.C.–Baltimore area ranks in the top six for life sciences R&D and manufacturing talent, according to a CBRE report. The Maryland Department of Commerce’s director of life sciences ...

The global Enzyme Replacement Therapy (ERT) market is poised for significant expansion, projected to reach USD 21.62 billion ...

Early intervention in psoriatic arthritis (PsA) is disease-modifying, and delays in diagnosis, even by 6 months, can reduce ...

AstraZeneca said on Thursday its experimental therapy gefurulimab met the main goal of a late-stage study looking into improving symptoms of a chronic, autoimmune condition known as generalised ...

RICHMOND, Va. (WDBJ) - Astrazeneca is deciding where in Virginia it will establish its newest multi-billion dollar ...

While Maryland remains a critical R&D hub for AstraZeneca, Virginia’s selection as the manufacturing cornerstone also highlights the state’s rising prominence in advanced pharmaceutical production, ...

Gov. Glenn Youngkin speaks with Janet Roach about pharmaceutical company AstraZeneca building a facility in Virginia.

Billy Joel’s 1st Wife Speaks Out About Their Marriage — and Why She Left ...

The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, alongside additional facilities in California, Indiana, Maryland, ...

Solvay S.A. (Brussels, Belgium) has taken a new step to reduce scope 3 greenhouse gas emissions by incorporating biogenic CO₂ ...